Bristol-Myers Squibb (BMY)
NYSE: BMY
· Real-Time Price · USD
47.74
0.59 (1.25%)
At close: Sep 11, 2025, 10:04 AM
Revlimid Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 838M | -98M | -10.47% |
Mar 31, 2025 | 936M | 738M | +372.73% |
Dec 31, 2024 | 198M | -92M | -31.72% |
Sep 30, 2024 | 290M | -134M | -31.60% |
Jun 30, 2024 | 424M | 50M | +13.37% |
Mar 31, 2024 | 374M | n/a | n/a |
Dec 31, 2023 | n/a | n/a | n/a |
Sep 30, 2023 | n/a | n/a | n/a |
Jun 30, 2023 | n/a | n/a | n/a |
Mar 31, 2023 | n/a | n/a | n/a |
Dec 31, 2022 | n/a | n/a | n/a |
Sep 30, 2022 | n/a | n/a | n/a |
Jun 30, 2022 | n/a | n/a | n/a |
Mar 31, 2022 | n/a | n/a | n/a |
Dec 31, 2021 | n/a | n/a | n/a |
Sep 30, 2021 | n/a | n/a | n/a |
Jun 30, 2021 | n/a | n/a | n/a |
Mar 31, 2021 | n/a | n/a | n/a |
Dec 31, 2020 | n/a | n/a | n/a |
Sep 30, 2020 | n/a | n/a | n/a |
Jun 30, 2020 | n/a | n/a | n/a |
Mar 31, 2020 | n/a | n/a | n/a |
Dec 31, 2019 | n/a | n/a | n/a |
Sep 30, 2019 | n/a | n/a | n/a |
Jun 30, 2019 | n/a | n/a | n/a |
Mar 31, 2019 | n/a | n/a | n/a |
Dec 31, 2018 | n/a | n/a | n/a |
Sep 30, 2018 | n/a | n/a | n/a |
Jun 30, 2018 | n/a | n/a | n/a |
Mar 31, 2018 | n/a | n/a | n/a |
Dec 31, 2017 | n/a | n/a | n/a |
Sep 30, 2017 | n/a | n/a | n/a |
Jun 30, 2017 | n/a | n/a | n/a |
Mar 31, 2017 | n/a | n/a | n/a |
Dec 31, 2016 | n/a | n/a | n/a |
Sep 30, 2016 | n/a | n/a | n/a |
Jun 30, 2016 | n/a | n/a | n/a |
Mar 31, 2016 | n/a | n/a | n/a |
Dec 31, 2015 | n/a | n/a | n/a |
Sep 30, 2015 | n/a | n/a | n/a |
Jun 30, 2015 | n/a | n/a | n/a |
Mar 31, 2015 | n/a | n/a | n/a |
Dec 31, 2014 | n/a | n/a | n/a |
Sep 30, 2014 | n/a | n/a | n/a |
Jun 30, 2014 | n/a | n/a | n/a |
Mar 31, 2014 | n/a | n/a | n/a |
Dec 31, 2013 | n/a | n/a | n/a |
Sep 30, 2013 | n/a | n/a | n/a |
Jun 30, 2013 | n/a | n/a | n/a |
Mar 31, 2013 | n/a | n/a | n/a |